HKD 74.70
+0.81%Price chart
Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18
Key dataSep 18, 2026
OpenHKD 74.85
From 52W high−40.24%
Volume2.54M
Market capHKD 41.79B
P/E (TTM)6.2x
P/S (TTM)4.5x
Div yield—
Key dataSep 18, 2026
Open
HKD 74.85
From 52W high
−40.24%
Volume
2.54M
Market cap
HKD 41.79B
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
6.1x
P/E (TTM)
6.2x
RSI (14)
41.9
MomentumView details →
1D Return
+0.81%
YTD Return
+3.75%
Similar companies
Latest newsMore news →
RemeGen Co., Ltd. repurchased 19,000 A-shares on the Shanghai Stock Exchange via centralized bidding on September 11, 2026, at RMB 113.2-113.7 per share for a total of RMB 2.1552 million, to be used for an employee equity incentive plan.9d agoChina's 2026 National Essential Medicines List took effect on September 1, adding 116 new drugs including four domestic Class 1 innovative drugs and Novo Nordisk's semaglutide.20d ago